Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordic Nanovector ASA – Mandatory notification of trade – settlement of PSUs

Oslo, Norway, 23 March 2022 Reference is made to the stock exchange announcement made by Nordic Nanovector ASA's (OSE: NANOV) (the "Company") on 31 January 2019, regarding allocation of 259,000 PSUs to employees in accordance with the authorisation granted at the Company’s annual general meeting held 30 May 2018 (the “2018 AGM”). Each vested PSU will give the holder the right to receive one share in the Company at an exercise price corresponding to the par value of the shares being NOK 0.20. The total program ended at 42,675 vested PSUs which were exercised on 22 March 2022. Out of

NOTICE TO THE ANNUAL GENERAL MEETING OF HEXPOL AB (publ)

Shareholders of HEXPOL AB are hereby summoned to the Annual General Meeting (AGM) to be held at 3 p.m. CET on Thursday, 28 April 2022 at Clarion Malmö Live at the address Dag Hammarskjölds torg 2, Malmö, Sweden. Due to the continued spread of the coronavirus, precautionary measures will be implemented in connection with the AGM. The AGM will be held as short as possible and no food will be offered after the AGM. Shareholders, proxy holders and assistants showing any symptoms of infection should refrain from participating in the AGM. Shareholders are encouraged to carefully consider the

Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg

Lund, Sweden, March 23, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced an update on the ongoing OPTIMIZE-1 clinical Phase Ib/II trial in first-line metastatic pancreatic cancer with the company’s lead asset, mitazalimab. Safety evaluation of the second dose-escalation cohort (900 µg/kg of mitazalimab in combination with mFOLFIRINOX) has concluded, which marks the successful completion of the Phase Ib part of the study. The Data Review Committee has declared the 900 µg/kg mitazalimab dose to be safe and recommended that the dosing level should be continued for the

BioStock: Immunicum’s strategy for fighting tumour recurrence

Tumour recurrence is the underlying cause of the majority of cancer deaths worldwide. It is thus considered one of the most pressing challenges within the oncology field. Swedish immuno-oncology company Immunicum is addressing this challenge with relapse vaccine candidate DCP-001, which is currently in phase II clinical stage. BioStock takes a closer look.Read the full article at biostock.se: https://www.biostock.se/en/2022/03/immunicums-strategy-for-fighting-tumour-recurrence/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Pihlajalinna starts repurchasing own shares for its M&A transactions and incentive programme

Pihlajalinna Plc                        Stock Exchange Release          23 March 2022 at 9.30 a.m.. Pihlajalinna starts repurchasing own shares for its M&A transactions and incentive programme The Board of Directors of Pihlajalinna Plc has decided to start repurchasing the company’s own shares on the basis of the authorisation given by the Annual General Meeting on 15 April 2021. The shares shall be repurchased to be used for M&A transactions and as part of the incentive programme. The maximum number of shares to be acquired is 120,000, corresponding to 0.53% of the total number

SciBase receives largest electrode order from a single clinic valued at 60k€

STOCKHOLM, SWEDEN, — March 23, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders,  announced today that it has received its single largest order to date from a single clinic. The order for nearly 2,000 electrodes was received from an existing customer, a private Dermatology clinic in Germany. The order was valued at around 60k€ and will be delivered in April. The company has seen a significant increase in order volume following the announcement of an 8% increase in electrode prices from April 1.“It is very

Realheart to establish Australian subsidiary

Press release 23 March, 2022 Realheart, who is developing the world's first artificial four-chamber heart, is setting up a subsidiary in Australia to take advantage of the knowledge and financial benefits offered by the Australian market related to product development and clinical trials.Scandinavian Real Heart Pty Ltd will be led and run by Dr Marianne Hellers, without any other employees. She holds a degree in Microbiology from Stockholm University and has extensive experience in the Australian life science community as well as a large network that can be valuable for Realheart in

Loomis announces new targets and presents strategy for 2022 – 2024

At the Capital Markets Day, which is held in a digital format today, Loomis announces new targets and presents an updated strategy under the heading “At the Centre of the Payment Ecosystem”.   The strategy means that Loomis will move further up the value chain by: 1) accelerating the core business, 2) increased focus on services with recurring revenue, 3) combining physical and digital customer offerings, 4) being the leading player in the market within ESG and 5) continuing to develop the Loomis model.   Loomis’ dividend policy, stating that 40 – 60 percent of annual net

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 75 - 23 MARCH 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Transactions in connection with share buy-back programme

On 3 March 2022, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2022. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 150 million. Please refer

XNK Therapeutics Reports First Patient Treated in Phase II Study in Multiple Myeloma

XNK Therapeutics AB (“XNK”) today announced that the first patient has been treated in a Phase II clinical study using XNK’s leading autologous natural killer (NK) cell-based candidate drug in combination with Sanofi’s anti-CD38 antibody Sarclisa (Isatuximab).“Having the first patient treated with NK cells in this clinical study is an important milestone in the clinical development of our leading drug candidate,” said Johan Aschan, CMO of XNK Therapeutics. “The study is progressing well, and we look forward to the results.” The present investigator-initiated, open, randomized, controlled,

Pihlajalinna starts a share-based incentive program

Pihlajalinna Plc             Stock Exchange Release              23 March 2022 at 9:00 a.m. Pihlajalinna starts a share-based incentive program The Board of Directors of Pihlajalinna Plc has adopted a share-based incentive program for the key persons of the company. The objective of the incentive program is to align the interests of the key persons with the interests of the Pihlajalinna shareholders in order to increase the value of the company. The program is to commit the key persons to the company and offer for the key persons a competitive compensation for superior performance. In

AFRY awarded the EPCM project for the Horizonte Minerals ferronickel project in Brazil

Araguaia Niquel Metais Ltda., a wholly owned subsidiary of Horizonte Minerals Plc, has awarded AFRY the Engineering, Procurement and Construction Management (EPCM) contract for the development of its Araguaia ferronickel project in Brazil.Nickel is a fundamental material in our everyday lives. As a critical component in both stainless steel and new battery technology, nickel is also a key enabler of the clean energy transition. New technology innovations, ethical behaviour as well as reduced water usage and a low carbon footprint are important priorities for new nickel mining operations and

New World Academic Forum launched in Stockholm

The World Academic Forum Stockholm Summit, an interdisciplinary stage with academics from different corners of the world, is being launched in May of 2022. A groundbreaking partnership comprising of 18 universities and university colleges in Stockholm welcomes academics and artists to join the conversation, on site and online.During four days in May (17-20) open-minded, interdisciplinary, and diverse talks will take place, inspired by a model known from Stockholm Explorative Talks. Timely topics within research will be addressed in new, and creative ways when academics are offered the

Worldwide hit game Ruzzle celebrates 10 years since global launch

From startup to viral phenomenon - A decade has passed since MAG’s successful word game Ruzzle was released. Today, the game is one of MAG's strongest evergreens, with a continued active and engaged player base.Stockholm, Sweden - 23 March, 2022 - March 2022 marks ten years since MAG Interactive's first major hit game Ruzzle's release, “MAG was in its infancy in 2012, we only had seven employees”, says Daniel Hasselberg, CEO of MAG Interactive. “When we started the development of Ruzzle, the team consisted of three people, two developers and an artist”. The game became popular in Sweden

Offering price for SLP’s initial public offering set at SEK 27.00 per share of series B – the trading on Nasdaq Stockholm commences today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEELAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.Swedish Logistic Property AB (“SLP” or the “Company”) today announces the outcome of the offer to the general public of the Company’s series B shares (the “Offering”) and the listing of the Company’s shares on Nasdaq Stockholm. The Offering attracted very strong interest,

Volvo Trucks sells 50 electric trucks to truck-as-a-service start up

American startup company WattEV has placed an order for 50 Volvo VNR Electric trucks. Over the next several months, the trucks will be deployed in WattEV’s Truck-as-a-Service model (TaaS). TaaS provides shippers and carriers access to Class 8 battery-electric trucks at a per-mile rate, including charging, that is on par with the total cost of operating diesel trucks.            50 VNR Electric trucks will be used in a Truck-as-a-Service business.“Volvo Trucks applauds WattEV’s unique approach to accelerating fleet electrification through its Truck-as-a-Service model, which aims to

Annual reports 2021 – Exchange-traded funds managed by Handelsbanken Fonder AB

The annual reports for the following exchange-traded funds have been completed for the full-year 2021 and will be released today. The reports are available on the Management Company’s websites at xact.se and handelsbanken.se/en/personal/savings/mutual-funds/fund-reports.   · XACT BEAR (ETF) · XACT BEAR 2 (ETF) · XACT BULL (ETF) · XACT BULL 2 (ETF) · XACT Norden (UCITS ETF) · XACT Nordic High Dividend Low Volatility (UCITS ETF) · XACT Obligation (UCITS ETF) · XACT OMXC25 (UCITS ETF) · XACT OMXS30 ESG (UCITS ETF) · XACT Svenska Småbolag (UCITS ETF) · XACT

Bulten signs FSP contract for a new European electric vehicle program

Bulten has signed an FSP (Full Service Provider) contract regarding the supply of fasteners for a new European electric vehicle program with a global automotive manufacturer, which is also an existing customer of the company. The contract value is approximately SEK 75 million annually at full capacity.“We are pleased to gain renewed confidence from an existing customer. It is through our knowledge and experience as a fastener manufacturer and FSP provider, together with a strong sustainability offer, that makes this possible,” says Markus Baum, Chief Commercial Officer of Bulten.

SEB’s CFO Masih Yazdi returns from leave of absence

Masih Yazdi will return from his leave of absence and resume his position as SEB’s Chief Financial Officer and member of the Group Executive Committee. Peter Kessiakoff, who has been Acting CFO during Masih Yazdi’s leave of absence, will resume his previous position as CFO of SEB’s division Corporate & Private Customers. The changes are effective immediately. “I am very glad to welcome Masih back and want to thank Peter for his dedicated and excellent work during this time,” says Johan Torgeby, SEB’s President and CEO.

Completed sale of shares in RevolutionRace

23 March 2022 THIS PRESS RELEASE IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN OR INTO THE U.S. (OR TO U.S. PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE

Electrolux reduces sea transport emissions by 15% in 2022

Electrolux will now use more sustainable fuels for 25% of its total sea freight. By partnering with shipping companies Maersk and CMA CGM Group to use biofuel based on waste oils and LNG (Liquefied Natural Gas), Electrolux will reduce its sea transport greenhouse gas emissions by 15 percent already in 2022.Electrolux is working toward halving its transport emissions by 2025. To reach this target two important agreements have been signed with shipping companies Maersk and CMA CGM. With the new agreements in place, 25% of Electrolux Group’s total sea freight will be transported using the most

There are no items matching the current filter
There are no more items matching the current filter
Back to top